0000899243-21-034143.txt : 20210825 0000899243-21-034143.hdr.sgml : 20210825 20210825161551 ACCESSION NUMBER: 0000899243-21-034143 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210823 FILED AS OF DATE: 20210825 DATE AS OF CHANGE: 20210825 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Burke William P. Mr. CENTRAL INDEX KEY: 0001682069 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 211207058 MAIL ADDRESS: STREET 1: HAEMONETICS CORPORATION STREET 2: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 FORMER NAME: FORMER CONFORMED NAME: Burke Willaim P DATE OF NAME CHANGE: 20160810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0402 BUSINESS ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-08-23 0 0000313143 HAEMONETICS CORP HAE 0001682069 Burke William P. Mr. 125 SUMMER STREET BOSTON MA 02110 0 1 0 0 EVP, Chief Financial Officer Common Stock 2021-08-23 4 M 0 11232 34.21 A 41523 D Common Stock 2021-08-23 4 M 0 11435 41.64 A 52958 D Common Stock 2021-08-23 4 S 0 22667 60.51 D 30291 D Non-qualified Stock Option (Right to Buy) 34.21 2021-08-23 4 M 0 11232 0.00 D 2020-10-25 2023-10-25 Common Stock 11232 0 D Non-qualified Stock Option (Right to Buy) 41.64 2021-08-23 4 M 0 11435 0.00 D 2021-06-06 2024-06-06 Common Stock 11435 0 D Transaction pursuant to an existing 10b5-1 trading plan. Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $60.06 to $60.88, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. This number includes unvested RSUs previously reported. /s/ Michelle Basil, attorney-in-fact for Mr. Burke 2021-08-25